Coronavirus India updates

  • Launch of 1000 Genome sequencing of SARS-Cov 2 Virus During a review of COVID 19 activities, DBT announced the launch of 1000 Genome sequencing of SARS-Cov 2 Virus by DBT Autonomous Institutions consortia to understand viral and host genomics of COVID-19 outbreak. This study will sequence 1000 SARS Cov-2 genomes from the clinical samples to understand the evolving molecular phylogeny of the virus and the emerging mutations in the viral RNA as well as identify the host genetic variations which correlate with transmission, susceptibility and disease severity. This study is being coordinated by NIBMG, Kalyani with active participation from CDFD, Hyderabad; ILS, Bhubaneswar; NCCS, Pune; InStem, Bengaluru along with other DBT Autonomous Institutions. The findings of this study will also assist development of efficient diagnostic assays, vaccine and drug candidates and help formulate policies for containment of the outbreak. Source: DBT
  • How coronavirus sparked a wave of innovation in India Entrepreneurs and innovators across India have responded quickly to the challenge posed by the COVID-19 pandemic. A host of new innovations, some emerging from start-ups that have been incubated by universities, have appeared in recent weeks….read more
  • RNA extraction kit Agappe Chitra Magna launched commercially for detection of COVID 19 Dr VK Saraswat, NITI Aayog member and President of Institute body of Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)announed here today the commercial launch of Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit for use during testing for detection of COVID-19….read more
  • CCMB testing twin modules to fight virus CSIR-CCMB, in the forefront of the scientific community’s coordinated battle against COVID-19, is working on two twin modules these days. One is sequencing of the coronavirus strain in large numbers to check for the varied ones prevalent across the country…read more
  • Machines used for testing drug-resistant TB can be now used for confirmation of COVID-19 cases Diagnostic machines used for testing drug-resistant tuberculosis can now be used for screening and confirmation of COVID-19 cases, the apex health research body, ICMR, said…read more
  • Coronavirus | Five hospitals enrol in ICMR study to assess efficacy of Hydroxychloroquine Five hospitals have enrolled so far for an observational study being conducted by ICMR to assess the efficacy of antimalarial drug hydroxychloroquine as a preventive medication against coronavirus (COVID-19) among health-care personnel. ….read more
  • Kangra Tea could lower coronavirus activity better than HIV drugs The Indian Council of Medical Research (ICMR) is likely to replace hydroxychloroquine (HCQ) with anti-HIV drugs to improve immunity and possibly reduce viral replication, in the revised protocol. However, the chemicals in Kangra tea could also be effective in boosting immunity as they can block coronavirus activity better than anti-HIV drugs…..read more
  • ICMR validates indigenous assays for COVID-19 diagnosis Indian researchers and authorities have prioritized to reduce dependence on other countries by developing and validating indigenous diagnostic assays for COVID-19 testing. A total of 11 RT-PCR-based indigenous assays were validated and recommended for the testingof COVID-19. This has been revealed by the Indian Council of Medical Research (ICMR)….read more
  • Comfortable face mask designed by CeNS could encourage public to use it for long hours A team of researchers at Centre for Nano and Soft Matter Sciences (CeNS), Bangalore, an autonomous institute of the Department of Science and Technology, have developed cup-shaped design (patent filed) of the mask that helps to create enough space in front of the mouth while speaking. It has been transferred to a Bangalore based company for mass production….read more
  • IIT-Guwahati takes ‘Trojan horse’ route to fight Alzheimer’s disease A war trick borrowed from Greek mythology, specifically poet Homer’s epic Iliad, could help reduce short-term memory losses associated with Alzheimer’s disease. Researchers at the Indian Institute of Technology-Guwahati (IIT-G) have, after a five-year study, arrived at methods for preventing the accumulation of neurotoxic molecules in the brain, which leads to memory loss….read more